Dear Friend,

This year Democracy Now! is celebrating our 25th anniversary—that’s 25 years of bringing you fearless, independent journalism. Since our first broadcast in 1996, Democracy Now! has refused to take corporate or government funding, because nothing is more important to us than our editorial independence. But that means we rely on you, our audience, for support. If everyone who tunes in to Democracy Now! gave just $4, we could cover our operating expenses for the entire year. Really, that’s all it would take. Right now a generous donor will TRIPLE your donation, making it three times as valuable to Democracy Now! Please do your part today, and thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Merck to Allow Generic Manufacturing of Pill That Reportedly Can Cut COVID-19 Deaths by Half

HeadlineOct 28, 2021

The pharmaceutical giant Merck said Wednesday it will share the formula for its COVID-19 therapeutic drug molnupiravir with poor countries, allowing manufacturers to produce cheap, generic versions of the antiviral pill. Merck says the drug can cut the risk of hospitalization or death in half. The People’s Vaccine Alliance applauded the move, tweeting, “It’s positive that unlike the grotesquely unequal distribution of Covid-19 vaccines, poorest countries won’t have to wait at the back of the queue for molnupiravir. BUT middle-income countries shouldn’t still be locked out.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top